Medical Health Cluster

Farmacos Covid19

CanSino Biologics recomienda la aplicación de una dosis de refuerzo de su vacuna Ad5-nCoV (Convidecia)

CIUDAD DE MÉXICO, MEX. Según los datos clínicos observados preliminarmente, CanSino Biologics (CanSinoBIO) de Tianjin, China, informó en Twitter que la aplicación de un refuerzo a los seis meses de la primera dosis con su vacuna anti-COVID-19 Ad5-nCoV (Convidecia), permite una multiplicación por ocho de los niveles de anticuerpos neutralizantes, brindando una mayor protección sin efectos adversos en […]

Read More

Un nuevo fármaco logra curar al 93% de pacientes con COVID grave: reciben en alta en 5 días

El EXO-CD24, desarrollado por el Centro Médico Sourasky en Tel Aviv, ya ha completado dos fases de ensayos sin registrar efectos secundarios relevantes. A pesar de que las vacunas contra la COVID-19 están cumpliendo con su misión de prevenir los diagnósticos graves y las muertes a causa de la enfermedad, los expertos insisten en […]

Read More

Florida Broke COVID-19 Records Several Times During Past Week

Florida reported a record-breaking number of daily COVID-19 cases three times during the past week, according to NBC News. The state is reporting more daily cases than any other state and accounts for 1 in 5 new infections nationwide. On Friday, Florida reported 23,903 daily cases, marking its highest 1-day total […]

Read More

Re-Engineered Tapeworm Drug Reduces SARS-CoV-2 Replication in Rodent Model

A group of medications long prescribed to treat tapeworm has inspired a compound that shows two-pronged effectiveness against COVID-19 in laboratory studies, according to a new publication appearing online in the journal ACS Infectious Disease. The compound, part of a class of molecules called salicylanilides, was designed in the laboratory […]

Read More

¿Nuevo tratamiento? Un fármaco que ha demostrado intervenir en la replicación viral del SARS-CoV-2.

Este nuevo fármaco ha demostrado intervenir en la replicación viral del SARS-CoV-2 y reducir la tormenta de citoquinas provocada por la Covid-19. Un grupo de fármacos utilizados para combatir la infección por el parásito tenia y otros virus, podría servir también como tratamiento contra la Covid-19 por evitar la replicación del virus y […]

Read More

Injectable Monoclonal Antibodies Prevent COVID-19 in Trial

A combination of two monoclonal antibodies given as a subcutaneous injection prevented COVID-19 in patients at a high risk of infection due to household exposure, according to results of a randomized, double-blind, placebo-controlled clinical trial published online August 4 in the New England Journal of Medicine. The cocktail of the monoclonal antibodies casirivimab and […]

Read More

Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2. Infectiona A Randomized Clinical Trial

Key Points Question  Does a single oral dose of azithromycin lead to absence of symptoms at day 14 in outpatients with COVID-19 compared with placebo? Findings  In this randomized trial that included 263 participants with SARS-CoV-2 infection, treatment with a single oral dose of azithromycin, 1.2 g, vs placebo resulted in self-reported […]

Read More